Impact of Treatment Modality on Vascular Function in Coarctation of the Aorta: The LOVE‐COARCT Study
Open Access
- 2 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (7) , e011536
Abstract
Background: Optimally treated patients with coarctation of the aorta remain at risk for late vascular dysfunction. The effect of treatment modality on vascular function is unknown. The LOVE‐COARCT (Long‐term Outcomes and Vascular Evaluation After Successful Coarctation of the Aorta Treatment) study was done to compare vascular function in patients with coarctation of the aorta treated with surgery, balloon dilation (BD), or stent implantation. Methods and Results: In treated coarctation of the aorta patients without residual coarctation, we prospectively compared aortic stiffness by applanation tonometry and cardiac magnetic resonance; endothelial function by endothelial pulse amplitude testing; blood pressure ( BP ) phenotype by office BP , ambulatory BP monitoring, and BP response to exercise; left ventricular mass by cardiac magnetic resonance; and blood biomarkers of endothelial function, inflammation, vascular wall function, and extracellular matrix. Participants included 75 patients treated with surgery (n=28), BD (n=23), or stent (n=24). Groups had similar age at enrollment, coarctation of the aorta severity, residual gradient, and metabolic profile, but differed by age at treatment. Prevalence of systemic hypertension, aortic stiffness, endothelial function, and left ventricular mass were similar among treatment groups. However, BD patients had more‐distensible ascending aortas, lower peak systolic BP during exercise, less impairment in diurnal BP variation, and lower inflammatory biomarkers. Results were unchanged after adjustment for potential confounders, including age at treatment. Conclusions: In our cohort of patients without residual coarctation, treatment modality was not associated with major vascular outcomes, even though there were some favorable vascular characteristics in the BD patients. Although this suggests that choice of treatment modality should continue to be driven by likelihood of achieving a good anatomical result, more long‐term studies are required to assess the clinical significance of the more‐optimal results of secondary markers of vascular function in BD patients. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 03262753.Keywords
This publication has 61 references indexed in Scilit:
- Vascular Health in Kawasaki DiseaseJACC, 2013
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease PredictionNew England Journal of Medicine, 2012
- Normal values of aortic dimensions, distensibility, and pulse wave velocity in children and young adults: a cross-sectional studyJournal of Cardiovascular Magnetic Resonance, 2012
- Comparison of Surgical, Stent, and Balloon Angioplasty Treatment of Native Coarctation of the AortaJACC, 2011
- Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’European Heart Journal, 2010
- Circulating Transforming Growth Factor-β in Marfan SyndromeCirculation, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady‐state free precession imaging sequencesJournal of Magnetic Resonance Imaging, 2003
- Transcutaneous angioplasty of experimental aortic coarctation.Circulation, 1982
- Preoperative and postoperative renin levels in coarctation of the aorta.Circulation, 1982